News About

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

Fri, 24 May 2013 04:04:24 -0400

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of PEG ratio.

United Therapeutics (NASDAQ: UTHR) has a PEG ratio of 0.28. United Therapeutics had $670.64 million in total cash for the latest quarter.

Dr. Reddy's Laboratories (NYSE: RDY) has a

Free Research Reports on RDY, TAM, VELT and XONE Issued by the Bedford Report

Wed, 15 May 2013 08:15:00 -0400

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

Dr. Reddy’s Q4 & FY13 Financial Results

Tue, 14 May 2013 06:08:00 -0400

US Stocks Seen Down on China Concerns

Tue, 14 May 2013 04:52:54 -0400

U.S. stock index futures signaled a lower open on Tuesday, as fears that China's central bank will not provide stimulus to boost its economy saw the Shanghai Composite fall to a one-week low.

Pleasant Surprises from the First Quarter

Wed, 01 May 2013 18:48:00 -0400

Despite dicey economic conditions, many of our holdings so far have posted remarkably strong earnings results.

Dr Reddys Laboratories: The Winning Streak Continues (RDY)

Tue, 30 Apr 2013 10:14:00 -0400

Dr. Reddy's to Release Q4 and Full Year FY13 Results on May 14, 2013

Tue, 30 Apr 2013 00:20:00 -0400

(MYL) Still Neutral on Mylan

Fri, 26 Apr 2013 13:54:11 -0400

We are maintaining our Neutral recommendation on Mylan Inc. (MYL) with a target price of $30.00....

Visit StockBlogHub to view complete post.

The Earnings Picture So Far

Wed, 17 Apr 2013 11:23:00 -0400

The operating performance of our holdings this quarter has been encouraging.

Indian Powerhouses

Mon, 15 Apr 2013 00:00:00 -0400

India’s economy, the fourth largest in the world, is expected to grow 6 percent year. But the Indian equity market has stalled. The Bombay Stock Exchange’s SENSEX Index is flat for the past 12 months, and was recently priced at 15.5 times earnings. This is a discount to most emerging markets as well as its long-term average of 17.6.

The lack of enthusiasm has a lot to do with the Indian government’s new austerity program, geared to bring the fiscal deficit to less than 5 percent of gross domestic product (GDP). Through 2014, government spending is expected to drop nearly 20 percent, as subsidies for essentials such as cooking oil, sugar, kerosene and fertilizer are slashed or eliminated.

Dr. Reddy’s Announces the Relocation of Their North America Headquarters and Establishment of a R&D Center in Princeton, NJ, USA

Tue, 09 Apr 2013 10:09:00 -0400

Dr Reddys Laboratories Rising Today on Above-Average Volume (RDY)

Mon, 08 Apr 2013 10:55:00 -0400

Dr. Reddy's Launches Generic Reclast – Analyst Blog

Fri, 05 Apr 2013 08:15:05 -0400

Dr. Reddy's Laboratories Ltd. (RDY) recently announced the launch of its therapeutic equivalent generic version of Novartis AG’s (NVS) Reclast (zoledronic acid 5 mg/100 mL) Injection in the US. The launch followed the approval by the US Food and Drug Administration (FDA) of the company’s Abbreviated New Drug Application (ANDA) for Reclast. Reclast is once-a-year [...]

Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection

Thu, 04 Apr 2013 01:55:00 -0400

Dr. Reddy’s Gets Ready

Wed, 03 Apr 2013 14:48:00 -0400

This generic drug maker based in India got a big boost this week from a landmark court ruling.

Dr. Reddy’s Appoints GV Prasad as Chairman and Satish Reddy as Vice-Chairman of the Company

Mon, 01 Apr 2013 07:32:00 -0400

Dr. Reddy’s Announces the Launch of Zenatane™ (Isotretinoin Capsules USP)

Fri, 29 Mar 2013 06:45:00 -0400

Dr. Reddy’s and Nordion Inc. (formerly MDS Inc.) Settle Claims

Fri, 22 Mar 2013 11:37:00 -0400

Stocks to Watch Today: Vical Incorporated, Prestige Brands Holdings, Dr. Reddy's Laboratories Limited, Kindred Healthcare

Fri, 22 Mar 2013 10:23:33 -0400

Lakeway, TX -- (SBWIRE) -- 03/22/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

TIP, AXHE: Big ETF Outflows

Fri, 15 Mar 2013 13:12:44 -0400

Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the iShares Barclays TIPS Bond Fund (TIP), which shed 4,500,000 shares, or a 2.6% decrease week over week. And on a percentage change basis, the ETF with the largest outflow was the iShares MSCI ACWI ex US Health Care Sector Index Fund (AXHE), which lost 50,000 of its shares, for a whopping 25.0% decline in outstanding shares.

Dr. Reddy's (RDY) Founder & Chairman Passes Away

Fri, 15 Mar 2013 11:15:11 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8188289 for the full story.

Dr. Reddy’s Laboratories Announces Dr. K. Anji Reddy Has Passed Away

Fri, 15 Mar 2013 11:12:00 -0400

Dr. Reddy’s Announces the Launch of Zoledronic Acid Injection

Tue, 05 Mar 2013 00:19:00 -0500

Dr. Reddy’s Holds 98.6% of the Shares in OctoPlus after the Post Closing Acceptance Period

Thu, 28 Feb 2013 01:40:00 -0500

RSI Alert For Dr. Reddy's Laboratories Ltd. (RDY)

Tue, 26 Feb 2013 12:06:59 -0500

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Transcept (TSPT) Notified of ANDA Filing for Generic Intermezzo by Dr. Reddy's (RDY)

Mon, 25 Feb 2013 16:30:10 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129924 for the full story.

If You’re Looking for Growth, Overlook India

Wed, 20 Feb 2013 01:05:41 -0500

UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Dr. Reddy's Laboratories After Disappointing 3Q

Fri, 15 Feb 2013 10:05:55 -0500

In a report published Friday, Citigroup reiterated its Buy rating on Dr. Reddy's Laboratories (NYSE: RDY), and raised its price target to $39.36.

Citigroup noted, “We rate DRL Buy with a Target Price of $39.36. REDY, in our view, is among the best placed to capitalize on the multiple

Free Research Report on Itron, Inc., Dr. Reddy's Laboratories Ltd., Intrepid Potash, Inc., Pinnacle Entertainment, Inc. and Sovran Self Storage, Inc.

Fri, 15 Feb 2013 08:00:00 -0500

BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral

Fri, 15 Feb 2013 06:43:55 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8104936 for the full story.

Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40

Thu, 14 Feb 2013 06:54:58 -0500

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8095002 for the full story.

Dr. Reddy's Q3 & 9 Months FY13 Financial Results

Thu, 14 Feb 2013 05:17:00 -0500

Earnings Scheduled For February 14, 2013

Thu, 14 Feb 2013 00:32:19 -0500

Alexion Pharmaceuticals (NASDAQ: ALXN) is expected to report its Q4 earnings at $0.53 per share on revenue of $316.49 million.

General Motors Company (NYSE: GM) is estimated to report its Q4 earnings at $0.51 per share on revenue of $39.14 billion.

Discovery Communications (NASDAQ: DISCA) is

Dr. Reddy's Announces Offer for OctoPlus is Unconditional

Tue, 12 Feb 2013 05:50:04 -0500

With reference to the joint press releases of Dr. Reddy's (NYSE: RDY) and OctoPlus (NYSE Euronext Amsterdam: OCTO), issued on 22 October 2012 and 13 December 2012 respectively, the Offeror and OctoPlus

Dr. Reddy's Declares Offer for OctoPlus Unconditional

Tue, 12 Feb 2013 03:32:00 -0500

Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield

Mon, 11 Feb 2013 01:51:33 -0500

Below are the top drug manufacturers-other stocks on the NYSE in terms of dividend yield.

Teva Pharmaceutical Industries (NYSE: TEVA) has a dividend yield of 2.10%. Teva's shares closed at $38.68 on Friday.

Novo Nordisk A/S (NYSE: NVO) has a dividend yield of 1.00%. Novo Nordisk's shares closed

Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013

Wed, 06 Feb 2013 01:22:00 -0500

The Real Story Behind HBI, OSIS, RDY and MOV

Wed, 30 Jan 2013 08:00:00 -0500

Watch for Continued Gains in Shares of Dr Reddys Laboratories (RDY)

Tue, 29 Jan 2013 10:40:00 -0500

A Peek Into The Market Before The Trading Starts

Fri, 25 Jan 2013 07:18:02 -0500

Pre-open movers US stock futures are higher this morning, as investors are awaiting new home sales data. Futures for the Dow Jones Industrial Average gained 32 points to 13,813.00 and S&P 500 index futures rose 3.20 points to 1,495.00. Nasdaq 100 futures climbed 9.75 points to 2,727.75.

A Peek Into Global Markets

Dr. Reddy's Launches Desloratadine ODT

Fri, 25 Jan 2013 05:54:13 -0500

Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on

Dr. Reddy’s Announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets)

Fri, 25 Jan 2013 00:34:00 -0500

Dr Reddys Laboratories: The Winning Streak Continues (RDY)

Tue, 22 Jan 2013 10:44:00 -0500

Dr Reddys Laboratories: The Winning Streak Continues (RDY)

Thu, 17 Jan 2013 13:12:00 -0500

GLD, HGEM: Big ETF Outflows

Fri, 11 Jan 2013 12:49:07 -0500

Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the SPDR Gold Shares (GLD), which shed 3,200,000 shares, or a 0.7% decrease week over week. And on a percentage change basis, the ETF with the largest outflow was the Health Care GEMS ETF (HGEM), which lost 50,000 of its shares, for a whopping 25.0% decline in outstanding shares.

Dr. Reddy’s Announces the Launch of Finasteride Tablets

Thu, 03 Jan 2013 00:35:00 -0500

(MYL) Another Generic Launch at Mylan

Tue, 01 Jan 2013 19:36:35 -0500

Mylan Inc. (MYL) recently announced that it has launched its generic version of Teva’s (TEVA)...

Visit StockBlogHub to view complete post.

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Wed, 19 Dec 2012 03:22:22 -0500

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.

The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is

A Peek Into The Market Before The Trading Starts

Fri, 14 Dec 2012 07:22:12 -0500

Pre-open movers US stock futures are higher this morning, as investors are awaiting consumer prices and industrial production data. Futures for the Dow Jones Industrial Average surged 43 points to 13,137.00 and S&P 500 index futures rose 4.30 points to 1,416.20. Nasdaq 100 futures climbed 3.75 points to 2,650.75.

A Peek Into

Dr. Reddy's Launches Cash Offer for OctoPlus for EUR 0.52/Share

Fri, 14 Dec 2012 06:07:58 -0500

Dr. Reddy's Laboratories Limited (NYSE: RDY) [“Dr. Reddy's”], together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V. (Euronext